Abstract:Intravenous (IV) thrombolysis is currently the most established treatment for acute ischemic stroke 1. Traditionally, patients with unruptured intracranial aneurysms have been deemed ineligible due to a theoretical increased risk of intracranial hemorrhage (ICH) from post-thrombolytic rupture of aneurysm. Recently, four retrospective studies indicated no significant difference in symptomatic ICH after intravenous thrombolysis between stroke patients with or without intracranial aneurysms 2-5. However, in most of these patients, the ischemic stroke mechanism was unrelated to the unruptured intracranial aneurysm. The safety of IV thrombolysis in acute ischemic stroke in the same territory of unruptured intracranial aneurysms remains unknown. We therefore present a case of pontine infarction due to a large unruptured intracranial aneurysm (17 mm in diameter) of the basilar artery where the patient received IV recombinant tissue plasminogen activator (rtPA) thrombolysis based on multimodal MR imaging. A 59-year-old man was admitted to the emergency room with a 4-h history of abrupt-onset right hemiparesis and dysarthria. He reported that the symptom severity increased during transport to the hospital. The patient had a past medical history of treated hypertension for 20 years and known basilar artery aneurysm for 2 years that had been managed conservatively. His blood pressure was 160/102 mmHg on admission. Neurological examination revealed normal conscious state, dysarthria, right hemiparesis, and sensory loss. His score on the National Institutes of Health Stroke Scale (NIHSS) was 6. A brain magnetic resonance imaging (MRI) scan (3.0T) was performed immediately. Diffusion-weighted imaging (DWI) revealed increased signal intensity in the left ventral pons (Figure 1A), indicating the presence of hyperacute infarction. Magnetic resonance angiography (MRA) showed a large unruptured intracranial aneurysm of the basilar artery (17 mm in maximal diameter) without basilar artery occlusion (Figure 1B). IV rtPA was administered immediately at a dose of 0.9 mg/kg body weight. His focal neurological deficit dramatically improved by the next morning. Twenty-four hours later, he was also administered an antiplatelet agent (aspirin 200 mg). He made a complete recovery and was discharged 6 days later (NIHSS 0). Our patient did not have any evidence of aneurysm rupture or ICH on his initial susceptibility-weighted imaging (SWI) scan, or on computed tomographic (CT) scan 2 h after thrombolysis (Figure 1C), and SWI at 24 h. There was no evidence of atherosclerotic disease on cervical CT angiography or carotid duplex ultrasonography. Noncontrast and contrast-enhanced T1 fast spin echo (FSE) sequences demonstrated abnormal blood flow with partial thrombosis of the aneurysm (Figure 2A and B). We hypothesize that the abnormal flow within the aneurysm (Figure 2C) leads to gradual thrombosis. Approximately 9.3% of stroke patients receiving intravenous thrombolysis have incidental aneurysms 2. Sometimes the intracranial aneurysms which presence is already known either being managed conservatively or already treated with clipping or coil embolization. On other occasions, the aneurysm is diagnosed during multimodal imaging performed to investigate the stroke. In acute stroke patients with pre-existing intracranial aneurysms, recent studies have suggested that intravenous thrombolysis may be safe given the similar rates of hemorrhagic transformation 2-5 and favorable 3-month clinical outcomes 5. There has been one report of anterior-communicating artery aneurysm rupture after IV rtPA for acute ischemic stroke 6. However, this case may have had a sentinel bleed from an intracranial aneurysm before the onset of ischemic stroke symptoms. Thus, it does highlight the necessity of carefully excluding previous aneurysm rupture before the administration of rtPA. Symptomatic acute ischemia in the territory of an unruptured intracranial aneurysm occurs rarely (approximately 1.3% of ischemic stroke patients) 7. Only two patients who have received thrombolysis in this context have been previously reported. One patient had a left middle cerebral artery aneurysm and received intravenous rtPA for their stroke 8. The other had a basilar tip aneurysm, and the stroke was treated with delayed intra-arterial rtPA 9. The largest aneurysms reported in patients who received rtPA have been approximately 8 mm in diameter 2, 3. Our case is the first report of acute ischemic stroke associated with an unruptured large intracranial aneurysm (17 mm diameter) of the basilar artery with successful treatment using IV rtPA. According to multimodal imaging analysis, thrombus was clearly observed in the aneurysm of the basilar artery. We hypothesize that the pontine infarct may have a potential association with the thrombus in the aneurysm. The fresh extension of intraluminal thrombus may have had lower platelet content, making it more susceptible to pharmacological thrombolysis. In conclusion, whilst it is difficult to estimate the risk of ICH after thrombolysis in acute ischemic stroke patients associated with intracranial aneurysms, our case indicates that at least some patients may benefit from IV rtPA. This case also suggests that multimodal imaging may assist physicians to identify the stroke mechanism and predict response to thrombolytic therapy. Dr. Lou receives research support from Zhejiang Provincial Natural Science Foundation of China (LR12H09001), the National Natural Science Foundation of China (81171095), and the Health Bureau of Zhejiang Province (WKJ2010-2-010). We thank Prof. Bruce Campbell (Royal Melbourne Hospital, University of Melbourne, Parkville, Vic., Australia) for English language correction. The authors have no actual or potential conflicts of interest to disclose.

Acute Diffuse And Transient Thyroid Swelling After Intravenous Thrombolysis For Acute Ischemic Stroke A Case Report

Alteration of Thyroid-Related Hormones Within Normal Ranges and Early Functional Outcomes in Patients with Acute Ischemic Stroke

Correlation between thyroid autoantibodies and intracranial arterial stenosis in stroke patients with hyperthyroidism.

Endovascular treatment of massive hemorrhage arising from inferior thyroid artery after fine needle aspiration of thyroid: a case report

“Sudden Drop” in Blood Pressure is Associated with Recanalization after Thrombolysis

A study on application value of susceptibility weighted imaging combined with platelet distribution width in intravenous thrombolysis for treatment of patients with acute cerebral infarction

No Hemorrhagic Transformation after Intravenous Thrombolysis in a Pontine Infarction Patient with Basilar Aneurysm.

[Factors Related to Therapeutic Outcomes of Intravenous Thrombolysis in Stroke Patients with Different Severity].

Prognostic value of subclinical thyroid dysfunction in ischemic stroke patients treated with intravenous thrombolysis.

Prognostic Value of Fluid-Attenuated Inversion Recovery Imaging Vascular Hyperintensity in Intravenous Thrombolysis of Acute Ischemic Stroke

Spinal subdural hematoma as a complication of tenecteplase treatment for acute ischemic stroke: A case report

Cerebrovascular Intervention Therapy Worked Positively in One Patient with Severe Cerebral Venous Sinus Thrombosis Due to Hyperthyroidism: a Case Report and Review of the Literature

Ipsilateral orolingual angioedema following rhTNK-tPA administration for acute ischemic stroke

Thyroid gland injury after blunt neck trauma: a case report

Delayed infected hematoma in retrosternal area following total thyroidectomy: a case report

Iatrogenic thyroid pseudoaneurysm following thyroid nodule radiofrequency ablation

Airway obstruction requiring tracheal intubation after fine-needle aspiration of the thyroid gland: a case report

Angioedema Secondary to Tenecteplase Use in a Patient with Acute Ischemic Stroke: A Case Report

Thyroid hormones and functional outcomes after ischemic stroke

Diagnosis and treatment approaches for simultaneous onset of subarachnoid hemorrhage and thyroid storm: a case report

Successful intravenous thrombolysis for acute ischemic stroke caused by aortic dissection with severe hypofibrinogenemia: a case report and literature review